Unio Capital LLC acquired a new stake in UnitedHealth Group (NYSE:UNH) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 20,276 shares of the healthcare conglomerate’s stock, valued at approximately $4,471,000. UnitedHealth Group comprises 3.7% of Unio Capital LLC’s portfolio, making the stock its 13th biggest position.
Several other institutional investors and hedge funds have also added to or reduced their stakes in UNH. Exane Derivatives boosted its position in shares of UnitedHealth Group by 15,333.3% in the 4th quarter. Exane Derivatives now owns 463 shares of the healthcare conglomerate’s stock valued at $102,000 after purchasing an additional 460 shares during the period. Aevitas Wealth Management Inc. acquired a new stake in shares of UnitedHealth Group in the 4th quarter valued at about $102,000. Pathstone Family Office LLC acquired a new stake in shares of UnitedHealth Group in the 4th quarter valued at about $129,000. Trustcore Financial Services LLC acquired a new stake in shares of UnitedHealth Group in the 4th quarter valued at about $133,000. Finally, Intellectus Partners LLC boosted its position in shares of UnitedHealth Group by 18.2% in the 2nd quarter. Intellectus Partners LLC now owns 818 shares of the healthcare conglomerate’s stock valued at $152,000 after purchasing an additional 126 shares during the period. Institutional investors and hedge funds own 86.78% of the company’s stock.
UNH opened at $230.32 on Tuesday. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.58. The company has a market capitalization of $217,027.44, a PE ratio of 22.87, a price-to-earnings-growth ratio of 1.31 and a beta of 0.77. UnitedHealth Group has a 12 month low of $164.96 and a 12 month high of $250.79.
The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 20th. Stockholders of record on Friday, March 9th were issued a $0.75 dividend. The ex-dividend date was Thursday, March 8th. This represents a $3.00 annualized dividend and a dividend yield of 1.30%. UnitedHealth Group’s dividend payout ratio is currently 29.79%.
UNH has been the subject of a number of research analyst reports. Zacks Investment Research raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $267.00 target price for the company in a research report on Saturday, January 20th. Goldman Sachs initiated coverage on UnitedHealth Group in a research report on Wednesday, January 3rd. They issued a “buy” rating and a $269.00 target price for the company. Credit Suisse Group upped their target price on UnitedHealth Group from $252.00 to $260.00 and gave the company an “outperform” rating in a research report on Wednesday, January 17th. Cantor Fitzgerald reissued a “buy” rating and issued a $280.00 target price on shares of UnitedHealth Group in a research report on Thursday, March 8th. Finally, Royal Bank of Canada upped their target price on UnitedHealth Group from $269.00 to $280.00 and gave the company an “outperform” rating in a research report on Wednesday, January 17th. Three equities research analysts have rated the stock with a hold rating and twenty-five have assigned a buy rating to the company. The stock currently has an average rating of “Buy” and a consensus price target of $244.62.
In other news, Director William C. Ballard, Jr. sold 10,000 shares of the firm’s stock in a transaction that occurred on Tuesday, January 23rd. The stock was sold at an average price of $246.38, for a total value of $2,463,800.00. Following the completion of the sale, the director now directly owns 76,637 shares of the company’s stock, valued at approximately $18,881,824.06. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Kenneth Irwin Shine sold 198 shares of the firm’s stock in a transaction that occurred on Friday, January 19th. The shares were sold at an average price of $242.55, for a total value of $48,024.90. Following the completion of the sale, the director now directly owns 1,790,567 shares of the company’s stock, valued at $434,302,025.85. The disclosure for this sale can be found here. Insiders sold a total of 77,015 shares of company stock valued at $17,879,199 over the last three months. Insiders own 0.89% of the company’s stock.
WARNING: This article was originally reported by Chaffey Breeze and is owned by of Chaffey Breeze. If you are accessing this article on another publication, it was illegally copied and republished in violation of US & international copyright & trademark law. The original version of this article can be viewed at https://www.chaffeybreeze.com/2018/04/17/unio-capital-llc-invests-4-47-million-in-unitedhealth-group-unh.html.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.